{
    "clinical_study": {
        "@rank": "131353", 
        "brief_summary": {
            "textblock": "RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing\n      so they stop growing or die. Giving the drugs in different ways may kill more tumor cells.\n\n      PURPOSE: Phase II trial to study the effectiveness of implanted carmustine wafers in\n      treating patients who have brain metastases and who are undergoing surgery to remove the\n      tumor."
        }, 
        "brief_title": "Carmustine Implants in Treating Patients With Brain Metastases", 
        "completion_date": {
            "#text": "April 2003", 
            "@type": "Actual"
        }, 
        "condition": [
            "Metastatic Cancer", 
            "Unspecified Adult Solid Tumor, Protocol Specific"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Neoplasm Metastasis", 
                "Neoplasms", 
                "Neoplasms, Second Primary"
            ]
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES:\n\n        -  Determine the local recurrence rate in patients with supratentorial metastatic brain\n           tumors undergoing surgical resection treated with polifeprosan 20 with carmustine\n           implant (Gliadel wafers).\n\n        -  Determine the incidence and time to recurrence at distant sites within the CNS in these\n           patients after this treatment.\n\n        -  Determine the median, 6-month, 1-year, and 2-year survival of these patients on this\n           regimen.\n\n        -  Determine the incidence and severity of cognitive function loss of these patients on\n           this regimen.\n\n        -  Determine the incidence and severity of CNS and systemic toxic effects of these\n           patients on this regimen.\n\n      OUTLINE: Patients receive up to 8 polifeprosan 20 with carmustine implants (Gliadel wafers)\n      implanted in the resected tumor cavity.\n\n      Patients are followed on day 7 or day of discharge, at 1 month, 3 months, every 3 months for\n      21 months, and then for survival.\n\n      PROJECTED ACCRUAL: A total of 90 patients will be accrued for this study within 30 months."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS:\n\n          -  Supratentorial brain metastases for which surgery is recommended\n\n               -  Solitary, unilateral, intracranial mass consistent with metastasis on MRI scan\n                  OR\n\n               -  Two brain lesions consistent with metastases on MRI scan\n\n               -  Lesions must be accessible through a single craniotomy\n\n               -  Metastatic lesions clearly distinct from tumor bed of any benign lesions\n\n               -  Intraoperative frozen section diagnosis of metastatic tumor from CNS lesion\n\n          -  No prior malignant intracranial neoplasm\n\n          -  No lesion(s) in the brainstem\n\n          -  No open communication of the resection cavity with the ventricle following resection\n\n        PATIENT CHARACTERISTICS:\n\n        Age\n\n          -  18 and over\n\n        Performance status\n\n          -  Karnofsky 60-100%\n\n        Life expectancy\n\n          -  At least 3 months\n\n        Hematopoietic\n\n          -  No concurrent hematologic disorders\n\n        Hepatic\n\n          -  No concurrent hepatic disease\n\n        Renal\n\n          -  No concurrent renal disease\n\n        Cardiovascular\n\n          -  No concurrent cardiac disease\n\n        Pulmonary\n\n          -  No concurrent pulmonary disorders\n\n        Other\n\n          -  Not pregnant or nursing\n\n          -  Fertile patients must use effective contraception\n\n          -  Mini mental score at least 15\n\n          -  No known hypersensitivity to carmustine or Gliadel wafers\n\n          -  No other serious concurrent medical illness or infection\n\n        PRIOR CONCURRENT THERAPY:\n\n        Biologic therapy\n\n          -  Not specified\n\n        Chemotherapy\n\n          -  Not specified\n\n        Endocrine therapy\n\n          -  Not specified\n\n        Radiotherapy\n\n          -  No prior cranial irradiation\n\n        Surgery\n\n          -  See Disease Characteristics\n\n          -  No prior surgery involving brain metastases or primary brain tumor(s) (except for\n             benign intracranial lesions such as pituitary adenoma, meningioma, or schwannoma)\n\n        Other\n\n          -  Concurrent systemic therapy allowed"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "November 1, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00003878", 
            "org_study_id": "CDR0000067044", 
            "secondary_id": [
                "NABTT-9802", 
                "JHOC-NABTT-9802"
            ]
        }, 
        "intervention": [
            {
                "intervention_name": "polifeprosan 20 with carmustine implant", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "conventional surgery", 
                "intervention_type": "Procedure"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Carmustine"
        }, 
        "keyword": [
            "unspecified adult solid tumor, protocol specific", 
            "tumors metastatic to brain"
        ], 
        "lastchanged_date": "June 20, 2013", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/NABTT-9802"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35294-3295"
                    }, 
                    "name": "University of Alabama at Birmingham Comprehensive Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tampa", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33612-9497"
                    }, 
                    "name": "H. Lee Moffitt Cancer Center and Research Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30322"
                    }, 
                    "name": "Emory University Hospital - Atlanta"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21231-2410"
                    }, 
                    "name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02114-2617"
                    }, 
                    "name": "Massachusetts General Hospital Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Detroit", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48202"
                    }, 
                    "name": "Henry Ford Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chapel Hill", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27599-7295"
                    }, 
                    "name": "Lineberger Comprehensive Cancer Center, UNC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Winston-Salem", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27157-1030"
                    }, 
                    "name": "Comprehensive Cancer Center at Wake Forest University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cleveland", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44195"
                    }, 
                    "name": "Cleveland Clinic Taussig Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19104-4283"
                    }, 
                    "name": "University of Pennsylvania Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78284-7811"
                    }, 
                    "name": "University of Texas Health Science Center at San Antonio"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "The Treatment of One or Two Supratentorial Brain Metastases With Surgical Resection and BCNU-Polymer Wafers", 
        "overall_official": {
            "affiliation": "Sidney Kimmel Comprehensive Cancer Center", 
            "last_name": "Alessandro Olivi, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00003878"
        }, 
        "source": "National Cancer Institute (NCI)", 
        "sponsors": {
            "collaborator": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "New Approaches to Brain Tumor Therapy Consortium", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2002", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2003"
    }, 
    "geocoordinates": {
        "Cleveland Clinic Taussig Cancer Center": "41.499 -81.695", 
        "Comprehensive Cancer Center at Wake Forest University": "36.1 -80.244", 
        "Emory University Hospital - Atlanta": "33.749 -84.388", 
        "H. Lee Moffitt Cancer Center and Research Institute": "27.951 -82.457", 
        "Henry Ford Hospital": "42.331 -83.046", 
        "Lineberger Comprehensive Cancer Center, UNC": "35.913 -79.056", 
        "Massachusetts General Hospital Cancer Center": "42.358 -71.06", 
        "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins": "39.29 -76.612", 
        "University of Alabama at Birmingham Comprehensive Cancer Center": "33.521 -86.802", 
        "University of Pennsylvania Cancer Center": "39.952 -75.164", 
        "University of Texas Health Science Center at San Antonio": "29.424 -98.494"
    }
}